Evidence map›Paper›PMID 34680756›Full record

ArticleAntibiotics (Basel, Switzerland)2021

Butyrate, Forskolin, and Lactose Synergistically Enhance Disease Resistance by Inducing the Expression of the Genes Involved in Innate Host Defense and Barrier Function.

Qing Yang, Melanie A Whitmore, Kelsy Robinson, Wentao Lyu, Guolong Zhang

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Qing YangDepartment of Animal and Food Sciences, Oklahoma State University, Stillwater, OK 74078, USA.ORCID 0000-0002-4108-9561
Melanie A WhitmoreDepartment of Animal and Food Sciences, Oklahoma State University, Stillwater, OK 74078, USA.
Kelsy RobinsonDepartment of Animal and Food Sciences, Oklahoma State University, Stillwater, OK 74078, USA.
Wentao LyuDepartment of Animal and Food Sciences, Oklahoma State University, Stillwater, OK 74078, USA.ORCID 0000-0001-8496-4525
Guolong ZhangDepartment of Animal and Food Sciences, Oklahoma State University, Stillwater, OK 74078, USA.ORCID 0000-0003-4781-5816
Oklahoma State University · US

Funding

U.S. Department of Agriculture 2018-68003-27462, 2020-67016-31619, 2018-67011-28041, 2021-67034-35184
6 · The paper itself

Abstract

The rising concern of antimicrobial resistance highlights a need for effective alternatives to antibiotics for livestock production. Butyrate, forskolin, and lactose are three natural products known to induce the synthesis of host defense peptides (HDP), which are a critical component of innate immunity. In this study, the synergy among butyrate, forskolin, and lactose in enhancing innate host defense, barrier function, and resistance to necrotic enteritis and coccidiosis was investigated. Our results indicated that the three compounds synergistically augmented the expressions of multiple HDP and barrier function genes in chicken HD11 macrophages. The compounds also showed an obvious synergy in promoting HDP gene expressions in chicken jejunal explants. Dietary supplementation of a combination of 1 g/kg sodium butyrate, 10 mg/kg forskolin-containing plant extract, and 10 g/kg lactose dramatically improved the survival of chickens from 39% to 94% (

Indexed as

antibiotic alternativesantimicrobial peptidesantimicrobial resistancebutyratecoccidiosisforskolinhost defense peptideslactosenecrotic enteritispoultry

Identifiers

PMID34680756
PMCPMC8532606
OpenAlexW3202367661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.